Sartorius Raises Guidance Following Strong First Half

Goettingen, - Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully closed the first six months of 2012, with substantial gains in order intake, sales revenue and earnings. The Bioprocess Solutions Division that primarily specializes in single-use products for pharmaceutical drug manufacture performed especially well. Furthermore, initial consolidation of the Biohit Liquid Handling business [...]

Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco

ST. LOUIS, -- Sigma-Aldrich® Corporation (NASDAQ:SIAL) announced today its Supelco® brand launched the Ascentis® Express C18, 5 micron particle size column to improve speed and increase efficiencies in high purity liquid chomatography (HPLC) procedures. The new columns are based on innovative Fused-Core® particle technology, which enables the production of columns capable of achieving greater speed [...]

QIAGEN automated workflow with QIAsymphony RGQ receives AOAC validation for detection of Salmonella in food samples

Providence, Rhode Island, and Hilden, Germany, - QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that its mericon® Salmonella spp. kit in combination with the QIAsymphony RGQ automation platform has received validation from the AOAC Research Institute, an independent third party organization that evaluates analytical methods for use in food safety and other testing. [...]

Horizon Discovery and NIH Center for Regenerative Medicine Collaborate to Apply rAAV Genome Editing

Cambridge, UK,: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced that it has signed a technology access agreement with the U.S. National Institutes of Health Center for Regenerative Medicine (NIH CRM), through Horizon’s Centers of Excellence (CoE) program. The agreement will enable the NIH CRM [...]

Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test

SUNNYVALE,Calif., --Cepheid (NASDAQ: CPHD) today announced the release of an updated Xpert BCR-ABL Monitor test, now incorporating lot-specific standardization using the WHO (World Health Organization) BCR-ABL standards. The test is being released as a European CE-IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid's GeneXpert [...]

3M Molecular Detection Assay for E. coli O157 (including H7) Receives AOAC-PTM Approval

ST. PAUL, Minn.-- Today, 3M Food Safety announced that it received AOAC-PTM Certification (#071202) for its new 3M™ Molecular Detection Assay for E. coli O157 (including H7) from the AOAC Research Institute’s Performance Tested MethodsSM Program. The certification gives food processors greater assurance in safeguarding against pathogenic E. coli, a causative agent of foodborne illness [...]

Cutting-edge Autofil™ Filtration System Eliminates Spills and Contamination

The Autofil™ Laboratory Filtration System is the latest addition to the growing line of Microbiology and Life Science products from Sterlitech Corporation. Vacuum-operated and designed to eliminate spills and contamination, the Autofil™ System features an ergonomically designed bottle and a stable pedestal that enables hands-free operation. This makes the system ideal for the preparation of [...]

Bruker Announces Preliminary Second Quarter 2012 Revenue and EPS, as well as Planned Earnings Release Date

BILLERICA, Mass.-- Bruker Corporation (NASDAQ: BRKR) announced today that based upon preliminary financial data the Company expects total second quarter 2012 revenue of approximately $420 million, compared to second quarter 2011 revenue of $401.2 million. For the second quarter of 2012, Bruker expects to report GAAP EPS in the range of $0.05 - $0.07, and [...]

OGT awarded €3 million from prestigious EU clinical research grants

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, announced today that its next generation sequencing service team has been awarded two EU- funded clinical research grants worth €3 million. OGT will be providing genomic analysis and commercialisation services for two key international studies, EUCLIDS and PATHSEEK. EUCLIDS [...]

Sigma-Aldrich Reports Q2 2012 Diluted EPS Of $0.94, With Diluted Adjusted EPS Of $0.97. Sales Increase 4% For Q2 2012. Expects Full Year 2012 Adjusted Diluted EPS Of $3.80 To $3.90.

HIGHLIGHTS: Q2 2012 Results (all percentages are to comparable periods in 2011) • Q2 2012 reported sales increased 4% to $664 million. Q2 2012 overall sales grew organically by 3% with Research and Sigma-Aldrich Fine Chemicals ("SAFC") organic sales growth of 1% and 8%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency [...]

Access IBO on Knowledge Center